Clinical Trials Logo

Renal Lithiasis clinical trials

View clinical trials related to Renal Lithiasis.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03836144 Completed - Glomerulonephritis Clinical Trials

Effect of Urine Alkalinazation on Urinary Inflammatory Markers in Patients With Cystinuria

Start date: April 2, 2015
Phase:
Study type: Observational

It has recently been described the presence of a urinary inflammatory signature in patients with cystinuria, the most common cause of renal lithiasis of genetical origin. These data are very innovative in this pathology but deserve further studies to establish the specificity of this inflammatory signature in patients with cystinuria compared to other nephropathies and other renal lithiasis diseases. Moreover, the effect of the usual treatment of cystinuria (namely urine alkalanization) on urinary inflammatory biomarkers deserves to be tested. The objectives of the present study are: i) To study the urinary inflammatory profile by mass spectrometry (a very efficient tool to detect and identify proteins) in patients with cystinuria and in patients with lithiasis of other origin and in patients with inflammatory renal disease ; ii) To study the potential effect of urine alkalinazation with potassium citrate (usual treatment according to European recommendations) on the inflammatory signature of patients with cystinuria. To this aim, urine of non treated cystinuric patients will be collected before treatement initiation and 3 months after the start of the alkalizing treatment.